Post-Publication Discussion Regarding Cytoreductive Surgery with or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer
- PMID: 35254577
- DOI: 10.1245/s10434-022-11501-8
Post-Publication Discussion Regarding Cytoreductive Surgery with or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer
Comment on
-
Letter to the Editor: Comment on ''Cytoreductive Surgery with or without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial''.Ann Surg Oncol. 2022 May;29(5):3351-3352. doi: 10.1245/s10434-022-11432-4. Epub 2022 Feb 15. Ann Surg Oncol. 2022. PMID: 35166953 No abstract available.
-
A Comment on a Recent Failed HIPEC Trial.Ann Surg Oncol. 2022 May;29(5):3359-3360. doi: 10.1245/s10434-022-11435-1. Epub 2022 Feb 15. Ann Surg Oncol. 2022. PMID: 35166954 No abstract available.
-
Enigma of Hyperthermic Intraperitoneal Chemotherapy with Interval Cytoreduction Surgery: Need to Push More Boundaries!Ann Surg Oncol. 2022 May;29(5):3355-3356. doi: 10.1245/s10434-022-11433-3. Epub 2022 Feb 20. Ann Surg Oncol. 2022. PMID: 35187619 No abstract available.
-
Combining HIPEC to Interval Surgery in Ovarian Cancer? One Step Forward with a Second Randomized Study: Comment on "Cytoreductive Surgery with or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer-A Phase 3 Clinical Trial".Ann Surg Oncol. 2022 May;29(5):3357-3358. doi: 10.1245/s10434-022-11434-2. Epub 2022 Feb 22. Ann Surg Oncol. 2022. PMID: 35192155 No abstract available.
-
The Debatable Role of HIPEC in Ovarian Cancer.Ann Surg Oncol. 2022 May;29(5):3353-3354. doi: 10.1245/s10434-022-11431-5. Epub 2022 Mar 7. Ann Surg Oncol. 2022. PMID: 35254576 No abstract available.
References
-
- Carneiro VCG, Ramalho NM. Letter to the editor concerning cytoreductive surgery with or without HIPEC after neoadjuvant chemotherapy in ovarian cancer: a phase 3 clinical trial. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11432-4 . - DOI - PubMed
-
- Paulino E, Melo AC. The debatable role of HIPEC in ovarian cancer. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11431-5 . - DOI - PubMed
-
- Raghavan S, Patel S, Prem A, Pandey D. Enigma of hyperthermic intraperitoneal chemotherapy with Interval cytoreduction surgery: need to push more boundaries. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11433-3 . - DOI - PubMed
-
- Noiret B, Bakrin N, Eveno C. Combining HIPEC to interval surgery in ovarian cancer? One step forward with a second randomized study. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11434-2 . - DOI - PubMed
-
- Chiva L, Harter P, Boria F, Ramirez P. A comment of a recent failed HIPEC trial. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11435-1 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
